9th Annual Biomarkers Congress

Drug Design: University of Pennsylvania

Total Score People Score Events Score
21 19 15
Date Event Presentation Speakers
June 4, 2013 World Pharma Congress Plenary Keynote Panel Discussion: Advancing Pharma R&D through Communication & Collaborations: Bio-Connectivity at Work Glen N. Gaulton
February 20, 2012 Advances and Progress in Drug Design Accelerated determination of a LEAD Steven M. Albelda
February 6, 2011 5th Drug Discovery for Neurodegeneration: An Intensive Course for Translating Research into Drugs After HTS: Solubility, Selectivity, Safety and Stability in Addition to Potency Kurt Brunden
Session Overview Kurt Brunden
Should You Start a Biotechnology Company? John S. Swartley
October 13, 2010 Making the Right Investments in Biomedical Informatics for Drug Development and Healthcare The progress the Sentinel Initiative has made towards meeting this ambitious mandate Mark Weiner, Sean Hennessy
Outcomes Research Validity Using an EMR Database Richard Tannen
August 23, 2010 The Ubiquitin Drug Discovery & Diagnostics Conference TBA Dan Vogl
July 11, 2010 Translational Cancer Medicine 2010 (USA) Genetic testing from breast and ovarian cancer: From risk assessment to therapeutic targeting Susan M. Domchek
HIFs, hypoxia, and tumor progression M. Celeste Simon
February 1, 2010 4th DRUG DISCOVERY FOR NEURODEGENERATION CONFERENCE Should You Start a Biotechnology Company? John S. Swartley
August 21, 2009 Eighth International Congress on Targeted Therapies in Cancer Novel Drug Development Strategies Drew Torigian
August 18, 2009 Second Annual Pre-Clinical/Clinical Development of Immunotherapies and Vaccines Expert Panel Discussion: Commonalities and Lessons Learned from Infectious Disease and Cancer Immunotherapy and Vaccine/Immunotherapy Development Programs Bruce L. Levine
Proactive Risk Management During Development: Ways to Improve the Probability of Success Paul Coplan
January 26, 2009 Biomarker Assay Development Genomics Technologies for Research and Clinical Applications Don A Baldwin
January 12, 2009 Model Based Drug Development KEYNOTE PRESENTATION ON PHARMACOMETRICS : Beyond PK/PD Modeling: The Use of Pharmacometrics to Increase Quantitative Decision Making, Reduce Speculation, and Increase FDA Approval Rates Jeffrey S Barrett
October 30, 2008 The Insiders' Take on Outsourcing - Building Value Without Owning the Infrastructure Business Roundtable Robert Booth
July 19, 2008 22nd Annual Symposium of The Protein Society Concurrent Morning Symposia 5: Protein Folding Dennis E. Discher
May 30, 2008 ASCO Annual'08 Meeting clinical trials-- Optimizing Your Clinical Trials Program (M18) Deborah Bruner
patient and survivor care-- Optimizing Your Clinical Trials Program (M18) Deborah Bruner
practice management and information technology-- Optimizing Your Clinical Trials Program (M18) Deborah Bruner
meet the professor sessions-- Optimizing Your Clinical Trials Program (M18) Deborah Bruner
December 1, 2007 47TH American Socieity of Cell Biology At the Limits: Optical Methods for Single Molecules, Cells, and Organisms John M Murray
Symposium VI Ballrooms A/B/C Dennis E. Discher
Stem Cell Force Generation and Differentiation. Dennis E. Discher
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.